US PA Philadelphia Falk MJ: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
|MiPNetLab=Polyak E | |MiPNetLab=Polyak E | ||
|Status=O2k 2008- | |Status=O2k 2008- | ||
|info=[http://www.oroboros.at/?IOC47 IOC47] | |||
|keyword=Respiratory OXPHOS disease | |keyword=Respiratory OXPHOS disease | ||
}} | }} | ||
Line 19: | Line 20: | ||
* ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]] | * ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]] | ||
Revision as of 06:20, 18 February 2014
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ